Why is 3B Blackbio falling/rising?

As of 16-Jul, 3B Blackbio DX Ltd is experiencing a decline in its stock price, currently at Rs 1,583.55, which reflects a decrease of Rs 26.45 or 1.64%. Today's price summary indicates that the stock has underperformed its sector by 1.07% and has fallen after two consecutive days of gains. The stock touched an intraday low of Rs 1,565, representing a 2.8% drop. In terms of returns, the stock has seen a 2.45% increase over the past month, but it has a year-to-date decline of 19.97%. Despite generating a 46.07% return over the past year, the company has reported flat results for the most recent quarter, with key performance metrics at their lowest levels, which may be contributing to the current price drop.
In the broader market context, the stock's short-term performance of -2.49% over the past week contrasts with the Sensex, which has declined by only 1.08%. This underperformance may indicate investor concerns about the company's recent financial results and valuation, as evidenced by a high Price to Book Value ratio and low domestic mutual fund holdings. While the company has demonstrated healthy long-term growth with an annual operating profit increase of 41.02% and consistent returns over the past three years, the current market sentiment appears cautious, particularly in light of the recent flat quarterly results and the stock's premium valuation compared to peers.